Recent Updates
Recently added Catalysts
XLO Positive Sentiment Score: 70/100

Xilio Therapeutics to Present at Upcoming Investor Conferences

Monday, February 27, 2023 1 min read
Key Takeaway: Xilio Therapeutics, a biotechnology company focused on tumor-activated immuno-oncology therapies, has announced its upcoming participation in two significant investor conferences. The Cowen 43rd Annual Healthcare Conference will take place on March 6, 2023, followed by the Oppenheimer 33rd Annual Healthcare Conference on March 13, 2023. Both events will feature presentations that can be accessed through the company's website, highlighting their commitment to investor engagement and transparency.

Market Sentiment Analysis

POSITIVE FACTORS

  • Xilio Therapeutics is actively engaging with the investment community.
  • Participation in major healthcare conferences indicates strong growth potential.
  • The company is showcasing its innovative tumor-activated immuno-oncology therapies.

Full Press Release Details

WALTHAM, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced its participation in the following upcoming investor conferences:
Cowen 43rd Annual Healthcare Conference on Monday, March 6, 2023, at 9:10 a.m. ET as part of a discussion called Novel Immuno-Oncology (IO) Corporate Panel.
Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, with a virtual presentation at 4:00 p.m. ET.
A live webcast of the presentations can be accessed under “Events & Presentations” in the Investors & Media section of the Xilio Therapeutics website at https://ir.xiliotx.com/. A replay of the webcasts will be archived on the website for 30 days following each presentation.
About Xilio Therapeutics
This press release contains hyperlinks to information that are not deemed to be incorporated by reference in this press release.
For Investor Inquiries:
xilio@argotpartners.com
For Media Inquiries:
Vice President, Corporate Communications

Frequently Asked Questions

What is Xilio Therapeutics focused on?

Xilio Therapeutics is focused on developing tumor-activated immuno-oncology therapies for cancer.

When is the Cowen Healthcare Conference presentation?

The Cowen 43rd Annual Healthcare Conference is on March 6, 2023, at 9:10 a.m. ET.

How can I watch Xilio's investor presentations?

Investors can watch presentations via live webcast on Xilio's website under 'Events & Presentations.'

What will happen after the webcasts?

The webcasts will be archived on the Xilio website for 30 days following each presentation.

Who to contact for investor inquiries at Xilio?

For investor inquiries, contact xilio@argotpartners.com.

Tags: XLO Viatris Investor Conferences Healthcare Xilio Therapeutics immuno-oncology investor conferences biotechnology
Last updated: Feb 27, 2023